Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO can be a frustrating condition for both patients and medical professionals, as it can take a long time to diagnose and treat. In this article, we will explore the medical abbreviation FUO and discuss the various causes, diagnosis, and treatment of this condition.
FUO is a medical abbreviation for fever of unknown origin. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO is defined as a fever that has persisted for more than three weeks without an identifiable cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The condition is most common in elderly patients, but can occur in any age group. It is important to note that FUO is not a specific disease, but rather a diagnosis of exclusion. This means that the cause of the fever must be determined before a diagnosis of FUO can be made.
The exact cause of FUO is often unknown, but there are many potential causes. These include infections, autoimmune disorders, malignancies, and medications. Infections are the most common cause of FUO, with viral infections such as influenza, mononucleosis, and HIV being the most common. Bacterial infections, such as tuberculosis, can also cause FUO. Autoimmune disorders, such as lupus, can also cause FUO. Malignancies, such as lymphoma and leukemia, can also cause FUO. Finally, medications, such as certain antibiotics, can also cause FUO.
The diagnosis of FUO is often a long and frustrating process. It involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The first step in diagnosing FUO is to rule out other causes of fever. This includes testing for infections, autoimmune disorders, malignancies, and medications. If these tests are negative, a diagnosis of FUO can be made. The next step in diagnosing FUO is to identify any underlying cause. This may involve further testing, such as additional laboratory tests, imaging studies, or biopsies. Once the underlying cause is identified, treatment can be tailored to the specific condition.
The treatment of FUO depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed. If an autoimmune disorder is the cause, immunosuppressive medications may be prescribed. If a malignancy is the cause, chemotherapy may be prescribed. If a medication is the cause, the medication may be discontinued.
Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The exact cause of FUO is often unknown, but there are many potential causes. The diagnosis of FUO involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The treatment of FUO depends on the underlying cause. FUO can be a frustrating condition for both patients and medical professionals, but with proper diagnosis and treatment, it can be managed effectively.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation